Language
Scientists from the University of Pittsburgh and other institutions stated in the latest research report published in the International Journal of Natural Immunity that blocking the \"immune memory checkpoints\" identified in immune cells m...
2020-10-07
Researchers at Princeton University have developed a systematic method to assess how the gut microbiota chemically transforms or metabolizes oral drugs, thereby affecting their safety and effectiveness...
2020-10-07SARS-CoV-2 is a virus that can destroy lung, liver and kidney tissues grown in the laboratory and may explain the serious complications of COVID-19 in the human body...
2020-10-07Previous studies have shown that the use of CD33 and CD123 redirected CAR-T cells to treat AML has shown effective anti-leukemia activity and is in the pre-clinical and late stages of clinical development...
2020-10-07Dr. Davidollings, director of the Seattle Children’s Institute of Immunotherapy Center, dreams of developing a treatment for children with type 1 diabetes for most of the past decade...
2020-10-07
According to a new study, among children and adolescents who received CD19 chimeric antigen receptor (CAR) T cell (CAR-T) injections, the infection rate increased in the first month after treatment and then decreased...
2020-10-07When used in mice with human glioblastoma, CAR-T cell therapy targeting CD133 appears to be successful because it reduces the tumor burden in these mice and increases them...
2020-10-07In a recent preliminary study conducted in China, 7 COVID-19 patients received intravenous injections of donor mesenchymal stem cells (MSCs)-pluripotent cells, which are believed to have immunomodulatory effects, as a result of this intervention Show...
2020-10-07Drug resistance has always been the main challenge we face in the fight between humans and cancer. In the latest research report published in the international journal Nature Communications, scientists at the University of California and other instit...
2020-09-30CAR-T cells can not only extend the survival period of cancer patients, but also improve the quality of life after treatment...
2020-09-30Yvonne Chen, associate professor at the University of California, Los Angeles and member of the Johnson Comprehensive Cancer Center, genetically modified immune cells such as T cells to attack the most evasive enemy: cancer...
2020-09-30Most cancer patients, such as multiple myeloma, will relapse after treatment. This harsh reality has led scientists to seek new cancer cell targeting mechanisms to improve the depth and tolerance of multiple myeloma treatments...
2020-09-30Tumors create an unfavorable environment for immune cells (such as T cells) that fight cancer...
2020-09-30According to the latest data released by researchers at the Abramson Cancer Center of the University of Pennsylvania, CAR-T cells that have undergone Crispr-Cas9 gene editing can persist in cancer patients for several months, and can stably prolifera...
2020-09-30In a new study, researchers from the University of Pennsylvania and Stanford University combined two state-of-the-art methods-CRISPR (DNA editing) and T cell therapy (using immune system sentinels to destroy tumors)...
2020-09-30X-chain chronic granulomatous disease (X-chain chronic granulomatous disease, X-CGD) is a rare inherited blood disease...
2020-09-30